Journal of Allergy and Clinical Immunology
Journal Abbreviation: J ALLERGY CLIN IMMUN
ISSN: 0091-6749
eISSN: 1097-6825
Publisher: Elsevier
Publications (38)
Novel insights into contact dermatitis (2022)
Johansen JD, Bonefeld CM, Schwensen JFB, Thyssen JP, Uter W
Journal article
Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis (2022)
Nocera AL, Müller SK, Workman AD, Wu D, McDonnell K, Sadow PM, Amiji MM, Bleier BS
Journal article
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. (2021)
Thalhammer J, Kindle G, Nieters A, Rusch S, Seppanen MRJ, Fische A, Grimbacher B, et al.
Journal article
Rubella vaccine–induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity (2021)
Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, et al.
Journal article
Depletion of CD56+CD3+ invariant natural killer T cells prevents allergen-induced inflammation in humanized mice (2021)
Ose R, Weigmann B, Schuppan D, Waisman A, Saloga J, Bellinghausen I
Journal article
A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice (2021)
Wolf K, Kühn H, Boehm F, Gebhardt L, Glaudo M, Agelopoulos K, Ständer S, et al.
Journal article
Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors (2020)
Shock A, Humphreys D, Nimmerjahn F
Journal article
Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry (2020)
Francuzik W, Ruëff F, Bauer A, Bilò MB, Cardona V, Christoff G, Dölle-Bierke S, et al.
Journal article
Mas-related G protein–coupled receptor X2 and its activators in dermatologic allergies (2020)
Kühn H, Kolkhir P, Babina M, Düll M, Frischbutter S, Fok JS, Jiao Q, et al.
Journal article, Review article
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results (2020)
Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, Bégin P, et al.
Journal article